Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Men with Kennedy disease have less chance of hair loss.

Hormones and genes affect hair growth and male baldness.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Prepubertal girls with hypertrichosis have more sensitive androgen receptors, leading to increased body hair growth.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

A new gene, JMJD1C, may affect testosterone levels in men.

Testosterone reduces knee flexibility by affecting relaxin receptors.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

A new genetic mutation causes severe Leydig cell hypoplasia, affecting sexual development.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.